- Albumin in Cell Culture Media – An examination of quality and functionPosted 15 hours ago
- Proving Clonality is a Hot Topic at Informa “Cell Line Development and Engineering” ConferencePosted 1 week ago
- Cell Culture and Single Cell Passaging of Human Pluripotent Stem Cells Without the Need for ROCK InhibitorPosted 1 week ago
- Generating Recombinant Versions of Human Serum-Derived Proteins – Transferrin and AlbuminPosted 2 weeks ago
- Poster: Purpose-designed Protein A resins for Improved Downstream Process and Cost Efficiency in MAb purificationPosted 3 weeks ago
- The CRISPR/Cas9 System and its ApplicationsPosted 3 weeks ago
- Upstream Continuous Process – Perfusion CulturePosted 4 weeks ago
- Gene Therapy Strengthened by Recent SuccessesPosted 1 month ago
- Airway Modeling using Advanced 3D Systems for Epithelial Cell CulturePosted 1 month ago
- Ask the Expert – Culturing epithelial cells using advanced 3D culture systems for airway modelingPosted 1 month ago
The Dish’s Weekly News Wrap Up – August 31, 2012
This week’s headlines include, Appeals Court rules on embryonic stem cell research, Top 25 Biotechs, innovative stem cell therapy developments, a new influenza vaccine study and Roche’s breast cancer drug promises longer survival. Cell Culture Events: Attend...
- Posted August 31, 2012
Defined Supplements – The Role of Recombinant Proteins in Biopharmaceutical Manufacturing
Defined supplements that improve growth, productivity and consistency are highly attractive for cell culture optimization projects. And, recombinant proteins are increasingly being used as defined supplements in biopharmaceutical, vaccine and stem cell manufacturing. The use of recombinant...
- Posted August 28, 2012
The Dish’s Weekly News Wrap Up – August 24, 2012
This week’s headlines include, innovative stem cell therapy trials, another vaccination success story, new breast cancer drug report, Myriad wins gene patent ruling, and the advantages of targeting rare diseases. “Chicken Pox Cases Fall 80% Over Decade:...
- Posted August 24, 2012
Venture Capital Investment in the Life Science Sector is Down for 2012 – Is There a Light at the End of the Tunnel?
Venture capital investment in the life science sector is down both in total number of venture dollars and number of deals according to the Dollar Drought Moneytree Life Sciences Report, published this month by Price Waterhouse Cooper....
- Posted August 23, 2012
The Dish’s Weekly News Wrap Up – August 17, 2012
This week’s headlines include, influenza and ebola vaccine developments, investment updates, the latest business deals, researchers get one step closer to regenerating the human heart and a new study shows promising results for use of an existing...
- Posted August 17, 2012